文献速递腹部MR

多中心验证简化MRI检测早期肝细胞癌

Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma.
PubMed 文献 · Radiology · 2023-01-24

这项多中心回顾性研究以手术病理为参考标准,评估动态对比增强简化MRI对早期肝细胞癌的检测效能。结果显示敏感度88.2%、特异度89.1%,但在Child-Pugh B或C级肝硬化患者中敏感度显著降低(64.1% vs 94.2%)。

要点

  • 简化MRI对早期HCC检测敏感度88.2%、特异度89.1%,适用于代偿期肝硬化。
  • Child-Pugh B或C级患者敏感度仅64.1%,显著低于A级的94.2%。
  • 采用LI-RADS v2018,>LR-3为阳性,简化序列包括冠状T2及轴位动态T1增强。

核心结论

  • 以手术病理为参考标准,动态简化MRI对代偿期肝硬化患者的早期HCC检测具有高敏感度和特异度,但对失代偿期肝硬化患者敏感度较低。

研究设计与样本

  • 回顾性研究,纳入美国三家肝移植中心2009年1月至2019年12月间接受肝切除或移植、术前3个月内行标准全肝MRI且无HCC定向治疗的患者。
  • 共纳入161例早期HCC患者(中位年龄62岁,123例男性)和138例无HCC患者(中位年龄55岁,85例男性),以手术病理为参考标准。
  • 从术前全肝MRI中选取冠状T2加权及轴位三维脂肪抑制T1加权动态增强(预对比、晚动脉、门静脉、延迟期)序列模拟简化MRI。
  • 每中心两名腹部放射科医师独立判读模拟简化检查,采用LI-RADS v2018,任何高风险肝脏观察(>LR-3)定义为阳性。

诊断标准与关键数值

  • 简化MRI检测早期HCC的敏感度为88.2%(142/161,95%CI:83.5-92.5),特异度为89.1%(123/138,95%CI:84.4-93.8)。
  • Child-Pugh B或C级肝硬化患者敏感度为64.1%,显著低于Child-Pugh A级的94.2%(P < .001)。
  • 采用LI-RADS v2018,>LR-3为阳性分类标准。

临床应用与阅片要点

  • 简化MRI可作为肝硬化患者HCC监测的替代方案,判读时采用LI-RADS v2018,>LR-3即视为阳性。
  • 对Child-Pugh B或C级患者,简化MRI敏感度明显下降,需警惕假阴性,必要时结合其他检查。

局限性

  • 回顾性研究设计。
  • 简化MRI为模拟生成而非实际采集。
  • 仅纳入接受手术且术前有标准MRI的患者,存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Abbreviated MRI is a proposed paradigm shift for hepatocellular carcinoma (HCC) surveillance, but data on its performance are lacking for histopathologically confirmed early-stage HCC. Purpose To evaluate the sensitivity and specificity of dynamic contrast-enhanced abbreviated MRI for early-stage HCC detection, using surgical pathologic findings as the reference standard. Materials and Methods This retrospective study was conducted at three U.S. liver transplant centers in patients with cirrhosis who underwent liver resection or transplant between January 2009 and December 2019 and standard "full" liver MRI with and without contrast enhancement within 3 months before surgery. Patients who had HCC-directed treatment before surgery were excluded. Dynamic abbreviated MRI examinations were simulated from the presurgical full MRI by selecting the coronal T2-weighted and axial three-dimensional fat-suppressed T1-weighted dynamic contrast-enhanced sequences at precontrast, late arterial, portal venous, and delayed phases. Two abdominal radiologists at each center independently interpreted the simulated abbreviated examinations with use of the Liver Imaging Reporting and Data System version 2018. Patients with any high-risk liver observations (>LR-3) were classified as positive; otherwise, they were classified as negative. With liver pathologic findings as the reference standard for the presence versus absence of early-stage HCC, the sensitivity, specificity, and their 95% CIs were calculated. Logistic regression was used to identify factors associated with correct classification. Results A total of 161 patients with early-stage HCC (median age, 62 years [IQR, 58-67 years]; 123 men) and 138 patients without HCC (median age, 55 years [IQR, 47-63 years]; 85 men) were confirmed with surgical pathologic findings. The sensitivity and specificity of abbreviated MRI were 88.2% (142 of 161 patients) (95% CI: 83.5, 92.5) and 89.1% (123 of 138 patients) (95% CI: 84.4, 93.8), respectively. Sensitivity was lower for Child-Pugh class B or C versus Child-Pugh class A cirrhosis (64.1% vs 94.2%; P < .001). Conclusion With surgical pathologic findings as the reference standard, dynamic abbreviated MRI had high sensitivity and specificity for early-stage hepatocellular carcinoma detection in patients with compensated cirrhosis but lower sensitivity in those with decompensated cirrhosis. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Kim in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Yokoo, Masaki, Parikh, et al. Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma. Radiology. 2023. PMID: 36692401. doi:10.1148/radiol.220917

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。